Overexpression or amplification of human epidermal growth factor receptor 2 (HER2) in bladder cancer correlates with tumor progression and poor prognosis, particularly being more prevalent in lymph node metastases (93). This evidence concerns the gene ERBB2 and urinary bladder cancer.